Nanomaterials to combat SARS-CoV-2 : Strategies to prevent, diagnose and treat COVID-19
Copyright © 2022 Valenzuela-Fernández, Cabrera-Rodriguez, Ciuffreda, Perez-Yanes, Estevez-Herrera, González-Montelongo, Alcoba-Florez, Trujillo-González, García-Martínez de Artola, Gil-Campesino, Díez-Gil, Lorenzo-Salazar, Flores and Garcia-Luis..
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the associated coronavirus disease 2019 (COVID-19), which severely affect the respiratory system and several organs and tissues, and may lead to death, have shown how science can respond when challenged by a global emergency, offering as a response a myriad of rapid technological developments. Development of vaccines at lightning speed is one of them. SARS-CoV-2 outbreaks have stressed healthcare systems, questioning patients care by using standard non-adapted therapies and diagnostic tools. In this scenario, nanotechnology has offered new tools, techniques and opportunities for prevention, for rapid, accurate and sensitive diagnosis and treatment of COVID-19. In this review, we focus on the nanotechnological applications and nano-based materials (i.e., personal protective equipment) to combat SARS-CoV-2 transmission, infection, organ damage and for the development of new tools for virosurveillance, diagnose and immune protection by mRNA and other nano-based vaccines. All the nano-based developed tools have allowed a historical, unprecedented, real time epidemiological surveillance and diagnosis of SARS-CoV-2 infection, at community and international levels. The nano-based technology has help to predict and detect how this Sarbecovirus is mutating and the severity of the associated COVID-19 disease, thereby assisting the administration and public health services to make decisions and measures for preparedness against the emerging variants of SARS-CoV-2 and severe or lethal COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Frontiers in bioengineering and biotechnology - 10(2022) vom: 07., Seite 1052436 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Valenzuela-Fernández, Agustín [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Genome sequencing |
|---|
| Anmerkungen: |
Date Revised 06.11.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fbioe.2022.1052436 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350194742 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350194742 | ||
| 003 | DE-627 | ||
| 005 | 20231226044437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fbioe.2022.1052436 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1167.xml |
| 035 | |a (DE-627)NLM350194742 | ||
| 035 | |a (NLM)36507266 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Valenzuela-Fernández, Agustín |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nanomaterials to combat SARS-CoV-2 |b Strategies to prevent, diagnose and treat COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2022 Valenzuela-Fernández, Cabrera-Rodriguez, Ciuffreda, Perez-Yanes, Estevez-Herrera, González-Montelongo, Alcoba-Florez, Trujillo-González, García-Martínez de Artola, Gil-Campesino, Díez-Gil, Lorenzo-Salazar, Flores and Garcia-Luis. | ||
| 520 | |a The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the associated coronavirus disease 2019 (COVID-19), which severely affect the respiratory system and several organs and tissues, and may lead to death, have shown how science can respond when challenged by a global emergency, offering as a response a myriad of rapid technological developments. Development of vaccines at lightning speed is one of them. SARS-CoV-2 outbreaks have stressed healthcare systems, questioning patients care by using standard non-adapted therapies and diagnostic tools. In this scenario, nanotechnology has offered new tools, techniques and opportunities for prevention, for rapid, accurate and sensitive diagnosis and treatment of COVID-19. In this review, we focus on the nanotechnological applications and nano-based materials (i.e., personal protective equipment) to combat SARS-CoV-2 transmission, infection, organ damage and for the development of new tools for virosurveillance, diagnose and immune protection by mRNA and other nano-based vaccines. All the nano-based developed tools have allowed a historical, unprecedented, real time epidemiological surveillance and diagnosis of SARS-CoV-2 infection, at community and international levels. The nano-based technology has help to predict and detect how this Sarbecovirus is mutating and the severity of the associated COVID-19 disease, thereby assisting the administration and public health services to make decisions and measures for preparedness against the emerging variants of SARS-CoV-2 and severe or lethal COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a genome sequencing | |
| 650 | 4 | |a lipid nanoparticles | |
| 650 | 4 | |a modified mRNA | |
| 650 | 4 | |a nanoreagents | |
| 650 | 4 | |a personal protective equipment | |
| 650 | 4 | |a recombinant proteins | |
| 650 | 4 | |a surveillance and diagnosis | |
| 650 | 4 | |a vaccines | |
| 700 | 1 | |a Cabrera-Rodriguez, Romina |e verfasserin |4 aut | |
| 700 | 1 | |a Ciuffreda, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Perez-Yanes, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Estevez-Herrera, Judith |e verfasserin |4 aut | |
| 700 | 1 | |a González-Montelongo, Rafaela |e verfasserin |4 aut | |
| 700 | 1 | |a Alcoba-Florez, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Trujillo-González, Rodrigo |e verfasserin |4 aut | |
| 700 | 1 | |a García-Martínez de Artola, Diego |e verfasserin |4 aut | |
| 700 | 1 | |a Gil-Campesino, Helena |e verfasserin |4 aut | |
| 700 | 1 | |a Díez-Gil, Oscar |e verfasserin |4 aut | |
| 700 | 1 | |a Lorenzo-Salazar, José M |e verfasserin |4 aut | |
| 700 | 1 | |a Flores, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia-Luis, Jonay |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in bioengineering and biotechnology |d 2013 |g 10(2022) vom: 07., Seite 1052436 |w (DE-627)NLM240045297 |x 2296-4185 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g day:07 |g pages:1052436 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fbioe.2022.1052436 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |b 07 |h 1052436 | ||